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The Latent Process Decomposition of
cDNA Microarray Data Sets
Simon Rogers, Mark Girolami, Colin Campbell, and Rainer Breitling
Abstract—We present a new computational technique (a software implementation, data sets, and supplementary information are
available at http://www.enm.bris.ac.uk/lpd/) which enables the probabilistic analysis of cDNA microarray data and we demonstrate its
effectiveness in identifying features of biomedical importance. A hierarchical Bayesian model, called Latent Process Decomposition
(LPD), is introduced in which each sample in the data set is represented as a combinatorial mixture over a finite set of latent processes,
which are expected to correspond to biological processes. Parameters in the model are estimated using efficient variational methods.
This type of probabilistic model is most appropriate for the interpretation of measurement data generated by cDNA microarray
technology. For determining informative substructure in such data sets, the proposed model has several important advantages over
the standard use of dendrograms. First, the ability to objectively assess the optimal number of sample clusters. Second, the ability to
represent samples and gene expression levels using a common set of latent variables (dendrograms cluster samples and gene
expression values separately which amounts to two distinct reduced space representations). Third, in constrast to standard cluster
models, observations are not assigned to a single cluster and, thus, for example, gene expression levels are modeled via combinations
of the latent processes identified by the algorithm. We show this new method compares favorably with alternative cluster analysis
methods. To illustrate its potential, we apply the proposed technique to several microarray data sets for cancer. For these data sets it
successfully decomposes the data into known subtypes and indicates possible further taxonomic subdivision in addition to highlighting,
in a wholly unsupervised manner, the importance of certain genes which are known to be medically significant. To illustrate its wider
applicability, we also illustrate its performance on a microarray data set for yeast.
Index Terms—cDNA microarray, latent variable modeling, cluster analysis.

1 INTRODUCTION
IN recent years, there has been a large growth in thevolume of microarray data. Machine learning techniques
have been very useful in extracting information from these
data sets. For example, unsupervised techniques such as
hierarchical cluster analysis have been used to indicate
tentative new subtypes for some cancers [1], [6] and to
identify biologically relevant structure in large data sets.
Using class labels, supervised learning methods will have
an increasingly important role to play in indicating the
detailed subtype of a disease, its expected progression, and
the best treatment strategy.
Cluster analysis is the most common data analysis
method used throughout the microarray literature. Genera-
tion of a dendrogram allows the inference of possible group
structure within the data and, thus, the identification of
related samples or functionally similar genes. A weakness
of clustering by dendrogram is that there is no natural way
to objectively assess the most probable number of structures
which underlie the data. Probabilistic model-based cluster-
ing can overcome this problem and clustering based on
mixtures of multivariate Gaussians has been proposed in
[9], for example. However, as the number of features (gene
probes) typically far exceeds the number of samples, the
estimated within-class covariances will be singular. There-
fore, extensive gene selection is a prerequisite to any
probabilistic model-based clustering and in [9] a further
level of feature extraction is required to obtain a sufficiently
low-dimensional subspace within which the clustering is
performed. For the purposes of biological interpretation, it
would be better if group structure could be identified using
the original set of genes probed in the microarray
experiment with the model used to identify those genes
responsible for the group structure. We will show that this
is achieved naturally by the model proposed in this paper.
The main assumption underlying most clustering meth-
ods, whether dendrogram-based or probabilistic, is that a
sample or gene is assigned exclusively to one class only.
While this may be appropriate if mutually exclusive classes
are inherent in the data, this assumption would not be valid
if a number of biological processes interact to influence a
given gene expression level, for example. Alternatively, a
sample might validly share some characteristics with two or
more sample clusters. It is therefore best to obtain models
which are not restricted by this mutual exclusion of classes
assumption.
Models overcoming this mutual exclusion assumption
have already been proposed in the literature. An example is
the Plaid Model of Lazzeroni and Owen [8] which allows
for overlaps between clusters. Another example is a model
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recently proposed by Segal et al. [10], in which a
probabilistic relational model (PRM) for gene expression
is developed. PRM is shown to successfully identify known
biological processes and provides improved interpretability
over comparable methods [10]. However, PRM requires an
estimation algorithm which, in its exact form, is NP-hard,
and so various heuristics are required to make the model
estimation tractable.
In this paper, we will present a new approach to the
analysis of microarray data which is motivated by the above
considerations and adopts the Latent Dirichlet Allocation
(LDA) approach to data modeling [2]. We have called the
method Latent Process Decomposition with a process
defined as a set of functionally related datapoints (samples
or genes). We use the term process, rather than cluster,
because a sample or gene can have partial membership of
several processes simultaneously, in contrast to many
cluster analysis approaches, as discussed above.
Latent Process Decomposition has linear computational
scaling in the number of genes, arrays andprocesses. It is able
to provide a representation of microarray data sets which
simultaneously reflects group structure across samples and
genes as well as the possible interplay between multiple
processes responsible for measured gene expression levels.
Furthermore, it has advantages over alternative approaches
such as the use of dendrograms, mixture models [9], Naive
Bayes, and other approaches. In Section 2, wewill outline the
method,with fullderivationandpseudocode listingsgiven in
theAppendix,while in Section 3,wewill outlineperformance
on medical and biological data sets. We have implemented
LPD in Matlab and Cþþ and this code is freely available at
http://www.enm.bris.ac.uk/lpd.
2 LATENT PROCESS DECOMPOSITION
2.1 Model Specification
In probabilistic terms, the data generation process for a
tissue sample can be described as follows (Fig. 1b): For a
complete microarray data set, a Dirichlet prior probability
distribution for the distribution of possible processes is
defined by the K-dimensional parameter . For a tissue
sample a, a distribution  over a set of mixture components
indexed by the discrete variable k is drawn from a single
prior Dirichlet distribution. Then, for each of the G features
g (generally uniquely mapping to genes), we draw a process
index k from the distribution  with probability k which
selects a Gaussian defined by the parameters gk and gk.
The level of expression ega for gene g from sample a is then
drawn from the kth Gaussian denoted as Nðegajk; gk; gkÞ.
This is then repeated for each of A tissue samples. It can be
easily seen that this generative process ensures that each
sample has its own specific distribution of processes and
that each measured level of gene expression in the sample is
obtained by repeatedly sampling the process index from the
sample-specific Dirichlet random variable , thus allowing
the possibility of a number of processes having an effect on
the measured levels of gene expression.
This is a biologically more realistic representation than
the mixture model which underlies all forms of clustering,
see Fig. 1a, where only one process or class is responsible
for all the measured gene expression, thus disregarding
gene-specific differences in effect (gk) and noise (gk) or the
sample-specific interaction of various processes.
2.2 Learning with Uniform Priors: The Maximum
Likelihood Solution
For a model with a set of parameters,H, and data D, Bayes’s
rule gives
pðHjDÞ / pðDjHÞpðHÞ; ð1Þ
where pðDjHÞ is the likelihood and pðHÞ is the prior on our
parameters H. We are interested in finding the set of
parametersH that maximizes pðHjDÞ (the maximum posterior
orMAP solution). In the case of a uniform (or uninformative)
prior, this is themaximum likelihood solution.Wewill begin
by deriving the maximum likelihood solution and then
extend this to a nonuniform (or informative) prior in
Section2.3.The log-likelihoodof a set ofA training samples is:
log pðDj; ; Þ; ð2Þ
which can be factorized over individual samples as follows:
log pðDj; ; Þ ¼
XA
a¼1
log pðaj; ; Þ: ð3Þ
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Fig. 1. Graphical model representations of LPD. (a) Cluster model structure. (b) LPD model structure.
Marginalizing over the latent variable  allows us to expand
this expression as follows:
log pðDj; ; Þ ¼
XA
a¼1
log
Z

pðaj; ; ÞpðjÞd; ð4Þ
where the probability of the sample conditioned on the
means, variances, and process weightings can be expressed
in terms of its individual components giving the following:
log pðaj; ; Þ¼ log
Z

YG
g¼1
XK
k¼1
Nðegajk; gk; gkÞk
( )
pðjÞd;
ð5Þ
where Nðajk; ; Þ denotes a normal distribution in process
k with mean  and standard deviation .
Variational inference can be employed to estimate the
parameters of this model and full details are given in the
Appendices. A lower bound on (5) can be inferred by the
introduction of variational parameters and the following
iterative update equations provide estimates of the two
variational parameters Qkga and ak
Qkga ¼ Nðegajk; gk; gkÞ exp  ðakÞ½ PK
k0¼1Nðegajk; gk0 ; gk0 Þ exp  ðak0 Þ½ 
; ð6Þ
ak ¼ k þ
XG
g¼1
Qkga; ð7Þ
for given k and where  ðzÞ is the digamma function. The
model parameters are obtained from the following update
equations:
gk ¼
PA
a¼1QkgaegaPA
a0¼1Qkga0
; ð8Þ
2gk ¼
PA
a¼1Qkgaðega  gkÞ2PA
a0¼1Qkga0
: ð9Þ
The update rule for the Dirichlet model parameter k is
found from the derivatives of the  dependent terms in the
likelihood [2]. Thus, the k are modified after each iteration
of the above updatings using a standard Newton-Raphson
technique (see [2, Appendix A.4.2], and the Appendix of
this paper for further details).
The generative process described above for samples can
equally be used over genes (the features). In probabilistic
terms: For each gene g, a Dirichlet random variable is
sampled, then for each experimental condition a, an index is
drawn with probability k, and then the expression level ega
is sampled from the appropriate Gaussian with mean and
variance ak, ak, respectively. Note that representing genes
in this manner only requires a change of indices in the
parameters which simply amounts to a transpose of the
expression matrix. We will give one example of a decom-
position over genes (the yeast cell cycle data set) later in
Section 3.2.1.
2.3 Learning with Nonuniform Priors: The MAP
Solution
In the previous section, we derived a set of update equations,
guaranteed to converge to a local maximum of the lower
bound on the likelihood.Wenowextend this argument to the
MAP solutionwith informative priors. A suitable prior on the
means could be a Gaussian distributionwith zeromean. This
would reflect a prior belief that most genes will be
uninformative and will have log-ratio expression values
aroundzero (i.e., they areunchanged compared to a reference
sample). For the variance, we may wish to define a prior that
penalizes overcomplex models and avoids overfitting. Over-
fitting may occur when Gaussian functions contract onto a
single data point causing poor generalisation and numerical
instability.With a suitable choice for the prior an extension of
our previous derivation to the full MAP solution is
straightforward. Our combined likelihood and prior expres-
sion is (assuming a uniform prior on ):
pð; ; jDÞ / pðDj; ; ÞpðÞpðÞ: ð10Þ
Taking the logarithm of both sides, we see that the
maximization task is given by:
; ;  ¼ argmax
;;
log pðGj; ; Þ þ log pðÞ þ log pðÞ:
ð11Þ
Thus, we can simply append these terms onto our bound
on (1). Noting that they are functions of  and  only (and
any associated hyperparameters), we conclude that these
terms only change the update equations for ak and ak. Let
us assume the following priors:
pðgkÞ / N ð0; Þ; ð12Þ
pð2gkÞ / exp 
s
2gk
( )
; ð13Þ
i.e., a zero-mean Gaussian for the means and an improper
prior for gk (i.e., not integrating to unity over its domain)
which gives zero weight to gk ¼ 0 and asymptotically
approaches 1 as gk approaches infinity. Plots of these priors
can be seen in Fig. 2 where  ¼ 0:1 and s ¼ 0:1.
Adding these to our original bound, we now have to
differentiate the following expression to obtain updates for
gk and gk
XA
a¼1
Qgka log pðegajgk; gkÞ þ log pðgkÞ þ log pðgkÞ: ð14Þ
Performing the necessary differentiations, we are left
with the following new updates
gk ¼
2
PA
a¼1Qgkaega
2gk þ 2
PA
a¼1Qgka
; ð15Þ
2gk ¼
PA
a¼1Qgkaðega  gkÞ2 þ 2sPA
a¼1Qgka
: ð16Þ
These expressions clearly show the effect of the priors. In
(15), we see that we now have a dependancy on both 2gk and
2. In the limit of
2
 !1, we effectively have auniformprior
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and we recover our original update equations for the
maximum likelihood solution. In the opposite limit of
2 ! 0, we find gk ! 0 as we would expect. In (16), the
prior is effectively putting a lower bound on the value of 2gk.
As s! 0, the prior approaches auniformdistribution over all
positive reals and we recover our original 2gk update.
2.4 Computing the Likelihood and Parameter
Initialization
Once the model parameters have been estimated, we can
calculate the likelihood for a collection of samples A0 using:
L ¼
YA0
a¼1
Z

YG
g¼1
XK
k¼1
Nðegajk; gk; gkÞk
( )
pðjÞd; ð17Þ
where we estimate the expectation over the Dirichlet
distribution by averaging over N samples drawn from the
estimated Dirichlet prior pðjÞ
L 
YA0
a¼1
1
N
XN
n¼1
YG
g¼1
XK
k¼1
Nðegajk; gk; gkÞkn
( )
: ð18Þ
Before iteratively updating Qkga, ak, gk, 
2
gk, and k
various parameter values need to be initialized. In the
numerical experiments reported below, the process mean
valuesgkwere initializedtothemeanexpressionvalueacross
the data set for each gene. Similarly, the variances2gkwere set
to the variance of their respective genes. The k values were
initialized to 1 for all k and the variational Dirichlet
parameters a were initialized to a positive random number.
3 NUMERICAL EXPERIMENTS
To evaluate the performance of Latent Process Decomposi-
tion (LPD) we applied it to four microarray data sets. For
the first three data sets (prostate, lung, and lymphoma
cancer), we show that LPD compares favorably with other
cluster analysis methods, including dendrograms and
Naive-Bayes, in its ability to classify samples. In the fourth
example for the yeast cell cycle [11], we show that LPD can
generate a rich, biologically relevant description of complex
experiments. In these numerical studies, the only prepro-
cessing was to take the logarithm of the data values (base 2)
if this had not already been performed by the originators of
the data set. Any likelihood calculations were approximated
by (18) where samples from pðjÞ were taken by using
k independent samples from gamma distributions with
parameters k and then normalizing the result to sum to 1.
The algorithm performs EM-like updates of the variational
and model parameters. As such, convergence is guaranteed,
although only to a local maximum of the training likelihood
and not to the global maximum. Therefore, any analysis
given below corresponds to the best solution (in terms of
the likelihood) achieved over several starts with different
initial a values.
When estimating the best value of K for a particular data
set, an N-fold cross-validation procedure was used. This
consisted of randomly partitioning the data into N subsets,
one of which would be removed before training and then
used to calculate the likelihood. Each of the N subsets
would be left out in turn and the N likelihood values would
be averaged to give the estimate of the true value.
3.1 Prostate Cancer Data Set
Our first cancerdata set comes froma studyofprostate cancer
by Dhanasekaran et al. [4] consisting of 54 samples with
9,984 features (weused their completedata set corresponding
to the supplementary information of [4, Fig. 8]). This data set
consists of 14 samples for benign prostatic hyperplasia
(labeled BPH), three normal adjacent prostate (NAP), one
normal adjacent tumour (NAT), 14 localized prostate cancer
(PCA), one prostatitis (PRO), and 20 metastatic tumours
(MET).Wewill use this data set to compareperformancewith
uniformpriors andnonuniformpriors and to compareLatent
Process Decomposition with hierarchical cluster analysis.
Fig. 3a shows the result of hierarchical cluster analysis
using a dendrogram with average linkage and a Euclidean
distance measure. Although some local structure can be
identified, we see that the dendrogram gives a poor
separation between known classes (in line with results
presented in Dhanasekaran et al. [4]). However, the number
of differentially expressed genes can be expected to be small
relative to the total number of genes. As an unsupervised
method we cannot use prior class knowledge but we can
use a prior belief that genes varying little across samples are
less likely to be interesting. Hence, to investigate the impact
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Fig. 2. Example priors for LPD gk and gk parameters. (a) Prior for gk. (b) Prior for gk.
of feature selection we ranked genes based on variance
across samples and used the subset of features with highest
variance. Fig. 3b shows the corresponding result for
performing hierarchichal clustering on this reduced data
set. Although the dendrogram manages to split metastatic
from the rest successfully, the difference between PCA and
BPH is still unclear and it is very difficult to infer from this
dendrogram just how many clusters are present.
In Fig. 4 (lower and descending curve) we give the hold-
out log-likelihood versus K, the number of processes, with a
uniform prior and using the top-ranked 500 features. The log-
likelihood peaks at about K ¼ 4 processes, after which a
model with uniform prior overfits the training data as we
increase thenumber ofprocesses. This is to be expectedwith a
maximum likelihood approach as we are allowing themodel
toomuch freedombynot penalising complexity. To solve this
problem,wecan incorporate the informativepriorsdiscussed
in Section 2.3. We will discuss the determination of the
parameters in these priors shortly. However, to illustrate
performancewegive the log-likelihood versusKplot in Fig. 4
(top, level curve) using values of 2 ¼ 0:1 and s ¼ 0:1.We see
that the log-likelihood remains approximately constant as the
number of processes is altered, rather than descending as K
increases.
Fig. 5a provides an explanation for this behaviour: this is a
decomposition of the prostate data into K ¼ 10 processes
with a uniform prior (and using the top 500 genes ranked by
variance). Given that the estimated optimum number of
processes is 4, we might expect the model to severely overfit,
as indeed it does. However, if we introduce priors with 2 ¼
0:1 and s ¼ 0:5, we obtain the decomposition seen in Fig. 5b.
Weobserve that thedecomposition is over just fourprocesses,
with the remaining six processes empty. This is very useful
since, given suitable values for the prior parameters, we do
not need to decide the exact number of processes. We also
notice that the decomposition is much cleaner. For example,
themetastatic samples (MET) have no overlap with localized
prostate cancer (PCA) and the benign and normal samples
indicating they are a distinct state.
Although we can avoid overfitting with correct para-
meters for the prior, this still leaves the question of the
correct choice of these prior parameters. Our numerical
investigations across different data sets indicated that the
mean parameter, , had negligible effect and we typically
set this parameter to 0:1. However, performance did
depend on s, the variance parameter. In Fig. 6, we plot
from a cross validation study of the log-likelihood versus s
for the 500 top-ranked genes in the prostate data set. We
notice a peak at s ¼ 0:1, though any choice for s on the
range 0:1 and 0:5 appears satisfactory.
It may appear that we have gained very little by moving
from cross-validation over processes to one over s, but
arguably this is not the case for two reasons. First, we are
dealing with a small number of samples and, hence, by
removing some samples for cross-validation, we could easily
remove a substantial proportion of one particular class,
suggesting a bias toward underestimating the number of
classes present. The variance parameter on the other hand is a
measure of noise that should be class independent and,
hence, should be the same regardless of whether or not the
full data set is being used. Also, the number of processes
presentwill bedependent on theparticular data set and could
vary greatly depending on the given study. On the other
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Fig. 3. Result of hierachichal cluster analysis on the prostate data set, using average linkage and a Euclidean distance measure. (a) Dendrogram
with all features. (b) Dendrogram with top-ranked 500 features.
Fig. 4. Hold-out log-likelihood (y-axis) versus the K (x-axis) using the top
ranked 500 genes in the prostate cancer data set using a nonuniform
prior as given in Section 2.3 (upper, level curve) and a uniform prior
(lower, descending curve) as described in Section 2.2.
hand, the contribution made by noise is a consequence of the
experimental procedure and we may expect the optimum
value of s to vary very little across data sets. Indeed, in the
following sections, we shall see that this is the case.
One advantage of LPD over standard clustering techni-
ques is the ease with which information can be extracted
from the derived model. In this prostate cancer example, we
could be interested in finding those genes most differen-
tially expressed between localized prostate cancer (PCA)
and the metastatic samples (MET), for example. The
following score can be used to rank genes:
Z ¼ jgi  gjjﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
2gi þ 2gj
q ; ð19Þ
where i and j correspond to the two processes being
compared. Genes ranking highly will be those with large
separation between their means and small standard
deviations—corresponding to genes whose values fall
consistently into two distinct clusters. In Table 1, we give
a list of the 10 top-ranked genes based on this score. Plots of
the mixture densities defined by the latent processes and
the actual data values for three of these genes can be seen in
Fig. 7. These three plots show that the extracted genes
appear to distinguish well between localized cancer and
metastasis and, importantly, have been highlighted as
significant without the use of the class labels. An investiga-
tion of these genes (Dr. Jeremy Clark, personal commu-
nication) indicates that some of them are potentially
significant for cancer biology. For example, CTGF is an
immediate-early gene induced by growth factors or certain
oncogenes. The expressed protein binds to integrins and
modulates the invasive behavior of certain human cancer
cells [3]. Similarly, it has been reported [5] that tumor
angiogenesis and tumor growth are critically dependent on
the activity of EGR1.
We have used the likelihood as our measure of model
performance. One issue that we have not yet explored is
how these likelihood values compare with those for
alternative, and possibly simpler, cluster analysis methods.
The most obvious comparison is with a standard Gaussian
mixture model. The main difference between LPD and a
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Fig. 5. K ¼ 10 process decomposition of the prostate cancer data set using the top 500 genes. The peaks represent the confidence in the
assignment of the ath sample to the kth process using ak. (a) With a uniform prior. (b) Using a nonuniform prior with 
2
 ¼ 0:1 and s ¼ 0:5.
Fig. 6. Hold-out log-likelihood (y-axis) as a function of the variance prior parameter s (x-axis) using the top 500 features in the prostate data set.
Gaussian mixture model is the repeated sampling for each
feature in LPD allowing each sample to be represented by a
combination of processes.
Due to the large number of features involved, it is
computationally infeasible to use a Gaussian mixture model
with full covariance matrices and thus we shall constrain
the matrices to be diagonal (equivalent to Gaussians aligned
with the coordinate axis). Fig. 8 shows the log-likelihood
curves using maximum likelihood (i.e., no priors) for LPD
and Naive-Bayes. We see that Naive-Bayes begins over-
fitting immediately, suggesting only two clusters in the
data. LPD rises above Naive-Bayes to a peak at K ¼ 4
processes before dropping toward the Naive-Bayes curve as
K increases. Although the difference in the log-likelihood is
not huge, it is statistically significant, given the error bars,
and the suggestion of only two clusters from Naive-Bayes is
misleading. Note that we have used the maximum like-
lihood approach for training LPD to give the fairest
comparison with Naive-Bayes which is also trained by
maximum likelihood. It is also worth noting the relative
sizes of the error bars. For Naive-Bayes, it is possible to
calculate the likelihood exactly, whereas with LPD we must
take samples from the Dirichlet. The error bars for the two
methods are certainly of the same order, suggesting that
most variation is due to the cross-validation procedure thus
allowing us to be confident in our LPD likelihood
approximation method.
3.2 Lung Cancer Data Set
The lung cancer data set [6] consists of 73 gene expression
profiles from normal and tumour samples with the tumors
labelled as squamous, large cell, small cell, and adenocarci-
noma. Ten-fold cross validation was performed for values of
K between 2 and 20 with and without parameter priors and
the results are shown in Fig. 9. As for the prostate cancer
example,wenotice anonuniformprior avoidsoverfitting and
causes the log-likelihood to plateau. In [6], the authors
identified seven clusters in the data—with the adenocarci-
noma samples falling into three separate clusters with strong
correlation with clinical outcomes. For their ordering (which
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TABLE 1
Top 10 Genes Separating Localized Prostate from Metastatic Prostate Cancer
Genes are ranked by Z.
Fig. 7. Inferred density plots for three genes separating localized prostate cancer (PCA, process 2) from the metastatic samples (MET, process 4) in
Fig. 5b. Actual data values are shown below the mixtures, separated by class with circles representing expression values for localized prostate
cancer and crosses representing values for metastatic prostate cancer samples. (a) Early growth response (EGR1). (b) Connective tissue growth
factor (CTGF). (c) Dopachrome delta-isomerase, tyrosine-related protein 2 (DCT).
Fig. 8. Hold-out log-likelihood (y-axis) for maximum likelihood LPD
(upper curve) and Naive-Bayes (lower curve) for various value of K
(x-axis). The top 500 features are used for both models.
we will follow), samples 1-19 belong to adenocarcinoma
cluster 1, samples 20-26 belong to adenocarcinoma cluster 2,
samples 27-32 are normal tissue samples, samples 33-43 are
adenocarcinoma cluster 3, samples 44-60 are squamous cell
carcinomas, samples 61-67 are small cell carcinomas, and
samples 68-73 are from large cell tumors. For this example
and the following data set (for lymphoma), features selection
was found to have little effect sowe give the analysis without
feature selection.
As in the previous section, the plateauing of the log-
likelihood with a nonuniform prior suggests that we are
using more processes than are necessary and additional
processes are left empty. The onset of a plateau in the log-
likelihood indicates the minimum number of processes to
use and K ¼ 10 would seem reasonable. The cross-valida-
tion study over s is given in Fig. 10 and we can see a peak
between 0:3 and 0:5. This is approximately the same peak
value found for the prostate cancer data set.
In Fig. 11, we use LPD to decompose the data into
10 processes with the bars representing the normalized
ak values (equivalent to EpðjaÞ½) and expressing the
confidence in the allocation of the ath sample to the
kth process. The samples are in the order in which they are
presented in the original paper [6].
First, we observe that the clustering by dendrogram is
accurately reproduced by latent process decomposition.
One notable difference is that the last two entries for the
small cell carcinoma grouping are placed with the adeno-
carcinoma cluster 2 by latent process decomposition with
high values of probability (close to one). For the original
clustering by dendrogram, these two samples are two
adenocarcinomas inaccurately placed by the dendrogram in
a cluster with small cell carcinomas. This difference is
therefore in favor of latent process decomposition. For
latent process decomposition, we find that the adenocarci-
noma clusters 1 and 2 decompose across processes 1 and 2
and adenocarcinoma cluster 3 is almost exclusively repre-
sented by process 4. There are rare instances of adenocarci-
noma placed in processes 9 and 10. The normal samples
(process 3) and large cell tumors (process 8) are very
distinct. The squamous cell carcinomas are decomposabled
into processes 5 and 6, both of which have little common-
ality with any other tumor types in the data set. This might
suggest possible further taxonomic decomposition into
subtypes. However, this possibility should be treated with
caution: decomposition into subprocesses could also mirror
the different genetic stages of a single subtype, for example.
In [6], the class labels were used to extract genes which
distinguished well between the different adenocarcinoma
clusters. Using the Z-score described in the previous
section, we give the top 10 ranked genes distinguishing
processes 1 and 4 (adenocarcinoma 1 and adenocarcinoma
3) in Table 2. Of these top genes, numbers 1, 2, and 10 were
discussed in [6] as being significant for cancer biology.
Also, the biological relevance of the detected genes is
highlighted by the internal consistency of the list: two
antagonistic proteins of sugar metabolism and a variety of
transmembrane proteins (including two solute carriers)
dominate the picture. Importantly, and in constrast to
Garber et al. [6], these features have been extracted with no
prior knowledge of class membership.1
Finally, as for the prostate cancer study, we can use the
hold-out log-likelihood to compare LPD with Naive-Bayes.
Again, we will use the maximum likelihood method to train
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Fig. 9. Hold-out log-likelihood (y-axis) versus K (x-axis) for the lung
cancer data set with (upper, level curve) and without parameter priors
(lower, descending curve).
Fig. 10. Hold-out log-likelihood (y-axis) as a function of s (x-axis) for the
lung cancer data set.
Fig. 11. Normalized ak values for a 10 process decomposition of the
lung cancer data.
1. For a more complete list and comparisons between other processes,
see http://www.enm.bris.ac.uk/lpd.
both models to ensure a fair comparison. The results can be
seen in Fig. 12. Although the difference between the two
methods is small, LPD tends to overfit less quickly as K
increases.
3.3 Lymphoma Cancer Data Set
Next, we consider the Lymphoma data set of Alizadeh et al.
[1], which consists of 96 samples of normal and malignant
lymphocytes. In this study, the authors used samples from
diffuse large B-cell lymphoma (DLBCL), the most common
form of non-Hodgkin’s lymphoma in addition to including
data for follicular lymphoma (FL), chronic lymphocytic
leukaemia (CLL), and other cell types.
Determining the hold-out log-likelihood versus K with
10-fold cross-validation, we find overfitting with a max-
imum likelihood solution while the log-likelihood plateaus
after K ¼ 10, suggesting this is the smallest number of
processes to use for a good fit to the data. Using K ¼ 10 we
can cross-validate over different values of the variance prior
parameter s and the results are shown in Fig. 13.
Adecomposition intoK ¼ 10processes (using the value of
s that gave themaximum in Fig. 13) can be seen in Fig. 14. The
samples are presented in the same order as Alizadeh et al. [1]
with samples 1 to 16 largely consisting of DLBCL with
samples 1 and 2 consisting of two DLBCL cell lines (OCI Ly3
and Ly10), while 10 and 11 are tonsil germinal cell samples.
Samples, 17 to 47 consist of DLBCL, samples 48 to 57, 58 to 63,
and 65 to 70 consist of bloodB andother samples, sample 64 is
the OCI Ly1 cell line, sample 71 is a single DLBCL sample
placed in with this general cluster of blood B and other
tissues, samples 72-80 are follicular lymphoma (FL), samples
85 to 95 are CLL, and 96 is a lone DLBCL sample. The
decomposition agrees well with the structure obtained using
a dendrogram [1]. Decomposition of the DLCL samples into
several processes suggests substructure supporting the
discussion in [1]. LPD and the dendrogram do differ, e.g.,
sample 71 (DLCL) is now partly grouped with the other
DLCL samples and not the FL samples in contrast to the
dendrogram.Also, process 6 brings together theOCI samples
which was not achieved by the dendrogram.
Finally, in Fig. 15, we compare the hold-out log-like-
lihood for LPD with that for the Naive-Bayes model. As in
the previous examples, we see that LPD does not overfit as
quickly and suggests a greater number of processes than the
Naive-Bayes model. It also gives a higher maximum value,
suggesting it is better suited to this particular data set.
3.4 Yeast Cell Cycle Data Set
For the next example, we have used the yeast cell cycle data
set of Spellmanet al. [11]. In this study, the authors investigate
which yeast genes show periodically varying expression
levels during cell cycle progression, using whole-genome
microarrays covering approximately 6,200 genes. Using a
cross-validation study of log-likelihood versus s with a
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TABLE 2
Top Lung Genes, Ranked by Z
Fig. 12. Hold-out log-likelihood (y-axis) for maximum likelihood LPD (top
curve for K ¼ 5) and Naive-Bayes (bottom curve for K ¼ 5) for various
value of K (x-axis).
Fig. 13. Hold-out log-likelihood (y-axis) versus the variance prior
parameter, s (x-axis), for the lymphoma data set.
Fig. 14. K ¼ 10 process decomposition of the lymphoma data.
nonuniformprior,we found the curveachieved itspeakvalue
at s ¼ 0 suggesting that anonuniformpriorwasnot of benefit.
Thus, the results in this section are presented using the
maximum likelihood solution of Section 2.2. In contrast to the
previous three examples, wewill nowdecompose over genes
rather than samples (see the end of Section 2.2). In Fig. 16, we
perform a comparison of the log-likelihood curves versus K
for threemethods and in all cases LPD gives the best solution
for these data sets.
Fig. 16 compares the predictive likelihood for LPD,
Naive-Bayes and a Bayesian network model introduced by
Segal [10]. Segal’s model decomposed the data into a set of
processes where each gene’s membership of each process is
defined by a separate binary variable. Each process has an
activity value defined for each array. The expression value
for a particular gene in a particular array is assumed to be
Gaussian where the mean is the sum of the activities for
each process to which this gene belongs. This method is
considered to be state-of-the-art and as such we have
included it in our comparisons. One problem with Segal’s
method is that estimating the binary membership para-
meters exactly is NP-hard and so for values of K greater
than 10, it becomes very time consuming. It is for this
reason that the likelihood curves for Segal’s method stops at
K ¼ 10 processes in Fig. 16. Various heuristics exist to
estimate these variables, but given the relative difference in
log-likelihood between this and the other two methods, it
seemed unnecessary to implement them.
While the previous data sets for cancer mainly demon-
strate the performance of LPD in categorising data, this cell
cycle data can reveal the biological usefulness of the
identified latent processes and their combinations in any
given sample. In this respect, LPD is able to provide a far
richer picture than is available from a simple clustering
approach. Fig. 16 shows that for this data set between 5 and
10 processes give the highest predictive likelihood. From
the well-characterized biology of the experiment, we expect
one process corresponding to each of the known cell cycle
phases (G1, S, G2, M, MG1, as defined in the original paper
[7]) plus a small number of “classifying” processes that
distinguish between the four different synchronization
methods that were used in the experiment. Fig. 17 shows
the 10 processes defined by LPD. It can easily be seen that
processes 1 and 3 represent “classifying” processes that
characterize alpha factor/elutriation synchronization and
CDC15 synchronization, respectively. Processes 2, 4, 6, and
8 correspond to cycling processes and each of them can be
uniquely mapped to one of the major cell cycle phases by
reference to the biological information given in [7] (high-
lighted in Fig. 17). The fifth cell cycle phase, G2, which is
very short in exponentially growing yeast cultures, is not
recovered as a distinct process but can easily be obtained by
the linear combination of the adjacent S and M phases (not
shown). The remaining processes (5, 7, 9, and 10) seem to be
dominated by noise and experimental artefacts (particularly
in process 7). This emphasizes that identification of the most
parsimonious number of latent processes is an extremely
useful feature of the LPD approach. This would be even
more important in experiments without previous knowl-
edge of the underlying process structure, where the
identification of the really informative processes would
not be as easy as in the present test case.
From a biological point of view, it is particularly
noteworthy that the cycling processes were identified
without any prior reference to the time-series structure of
the experiment. The original publication used a Fourier
transformation to determine the expression peaks of
cyclically expressed genes and Pearson correlation with
known cell cycle-regulated genes to assign them to cell cycle
phases. In the case of LPD, the same can be achieved by
reference to the gene-specific variational parameter gk. This
is shown in Fig. 18, where the expression of a classical G1
phase marker gene (cyclin CLN2) is indeed represented
most strongly by process 2, which according to Fig. 17,
corresponds to peak expression in G1.
Fig. 19 shows amore complex example of the power of this
approach. Thehistone genes,which code for themainprotein
component of chromosomes, are known to be most strongly
expressed in S phase, when new chromosomes need to be
assembled. Indeed, Fig. 19 shows that expression of one
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Fig. 15. Hold-out log-likelihood (y-axis) as a function of K (x-axis) for
maximum likelihood LPD and the Naive-Bayes Gaussian mixture model.
Fig. 16. Comparison of the log-likelihood (y-axis) versus K (x-axis) for
LPD (top curve) and a Naive-Bayes mixture model (middle curve). We
have additionally made a comparison with a Bayesian Network model
introduced by Segal et al. [10] (bottom curve) which represents process
membership over genes rather than samples.
representative histone (H1) is dominated by the S phase-
specific process 8 (compare Fig. 17). However, there are also
significant contributions by processes 2 and 6 (G1 and
M phase) and the measured expression profile (solid line in
Fig. 19, lower panel) shows clearly that this specific histone
has a much broader expression range that extends well
beyond S phase. This is not entirely unexpected as the
production of histone proteins shouldprecede the replication
of DNA that defines S phase.
4 CONCLUSION
Our experimental results strongly indicate that latent
process decomposition is an effective technique for dis-
covering structure within microarray data. It has several
advantages over the use of dendrograms or simple
clustering: unambiguous determination of the number of
processes via cross-validation using a hold-out (predictive)
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Fig. 17. The 10 processes identified by LPD for the yeast cell cycle. The cycling processes peak in the various phases of the cell cycle as highlighted
on subplots 2, 4, 6, and 8. The four different synchronization methods are indicated at the top. Our numbering convention is odd numbers starting
from the top subfigure for the left-hand figures and even numbers starting from the top for the right-hand figures.
Fig. 18. The expression levels of the G1-specific cyclin CLN2 YPL256C
peaks in G1 phase (lower panel, solid line). The dotted line is the sum of
the mean for each process weighted by the value of the gene-specific
variational parameter for each process (top bar chart). In this case, it can
be seen that the second process profile (G1 phase) is indeed dominant
for this gene.
Fig. 19. The expression levels of the histone H1 gene (YPL127C) peaks
in S phase (lower panel, solid curve). The dotted line is the sum of the
mean for each process weighted by the value of the gene-specific
variational parameter for each process (top bar chart). In this case, it can
be seen that a combination of the second, sixth, and eighth process
profiles is required for this histone. This combination corresponds to the
G1, M, and S phase processes identified by LPD (Fig. 17).
likelihood. In addition, the model uses a shared latent space
with the same explanatory variables for both samples and
genes. Overfitting can be effectively controlled using a
nonuniform prior, in contrast to many cluster analysis
methods. Also, several processes can be simultaneously
combined to determine gene expression levels so that the
relationship between processes is more transparent. LPD
has significant advantages over other cluster analysis
methods, for example, models based on a mixture of
Gaussians [9]. With the latter models, genes must be
preselected followed by another level of feature extraction
due to the rank deficiency of the estimated covariance
matrix in the original space. This is not required in the
approach advocated here. Given the large number of
features used by microarray data sets, there is a redundancy
of information. For this reason, we found that feature
selection can sometimes improve the performance of the
model. For lung and lymphoma data sets, we used no
feature selection, but for the prostate cancer and cell cycle
data sets, we used the top 500 and 1,000 genes as selected by
variance spread. Feature selection in this context is an
avenue for further research.
APPENDIX A
In this appendix, we will give a full derivation of the LPD
model. We will outline the derivation of the maximum
likelihood solution given in Section 2.2: the generalization
to a nonuniform prior is straightforward and outlined in
Section 2.3. The likelihood of a set of A training samples is
as follows:
YA
a¼1
pðaj; ; Þ ¼
YA
a¼1
Z

pðaj; ; ÞpðjÞd; ð20Þ
where the probability of the sample conditioned on the
means, variances, and process weightings can be expressed
in terms of its individual components giving the following:
YA
a¼1
pðaj; ; Þ¼
YA
a¼1
Z

YG
g¼1
XK
k¼1
Nðegajk; gk; gkÞk
( )
pðjÞd:
ð21Þ
For a concave function fðxÞ, Jensen’s inequality states
that f EpðzÞ½z
   EpðzÞ½fðzÞ, where EpðzÞ ¼ R zpðzÞdz for
continuous z. Thus, introducing a set of sample-specific
variational Dirichlets pðjaÞ, we can derive a lower bound
on the log-likelihood
XA
a¼1
log pðaj; ; Þ 
XA
a¼1
EpðjaÞ log pðaj; ; Þ
pðjÞ
pðjaÞ
  
;
ð22Þ
where
EpðjaÞ fðÞ½  ¼
Z

fðÞpðjaÞd: ð23Þ
A set of variational parameters Qkga are now introduced
such that
P
k Qkga ¼ 1 for bounding pðaj; ; Þ in the above
inequality. These parameters can be regarded as the
posterior distribution over the different processes for each
g and a. Jensen’s inequality can then be used again to give
the following additional bound
XA
a¼1
log pðaj; ; Þ
XK
k¼1
XA
a¼1
XG
g¼1
Qkga log
Nðegajk; gk; gkÞk
Qkga
 
:
ð24Þ
Combining these bounds into one gives the followingX
a
log pðajb; ; Þ 
X
a
EpðjaÞ½log pðjÞ

X
a
EpðjaÞ½log pðjaÞ
þ
X
a
X
g
X
k
Qkga logNðegajk; gk; gkÞ

X
a
X
g
X
k
Qkga logQkga
þ
X
a
X
g
X
k
QkgaEpðjaÞ½log k:
ð25Þ
A.1 Model Parameters
The process mean and variance parameters gk and 
2
gk only
appear in the third term of (25). This term can be expanded
as follows:X
a
X
g
X
k
Qkga logNðegajk; gk; gkÞ ¼
X
a
X
g
X
k
Qkga log
1ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
22gk
q
2
64
3
75X
a
X
g
X
k
Qkga
ðega  gkÞ2
22gk
:
ð26Þ
Taking partial derivatives of this expression with respect
to gk and gk, setting the results to zero and solving yields
the following updates
gk ¼
P
a QkgaegaP
a Qkga
; ð27Þ
2gk ¼
P
a Qkgaðega  gkÞ2P
a Qkga
: ð28Þ
The  parameter only appears in term 1 of (25), but
partial differentiation of this term with respect to k reveals
that a simple iterative procedure is not possible and a
second order technique is required. Term 1 can be writtenX
a
EpðjaÞ½logðpðjÞ ¼
X
a
EpðjaÞ log
ðPk kÞQ
k ðkÞ
 
þ log
Y
k

ðk1Þ
k
" #
:
ð29Þ
Thus, differentiating this expression we get
gi ¼ A  ð Þ   ið Þ½  þ
XA
a¼1
 iað Þ   að Þ½ ; ð30Þ
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from which we can derive the corresponding Hessian
Hij ¼  0 ð Þ  ijA 0 ið Þ; ð31Þ
new ¼ old HðoldÞ1gðoldÞ; ð32Þ
where HðÞ is the Hessian matrix and gðÞ is the gradient.
For i; j ¼ 1; . . . ;K, their components are given by:
gi ¼ A  ð Þ   ið Þ½  þ
XA
a¼1
 iað Þ   að Þ½ ; ð33Þ
Hij ¼  0 ð Þ  ijA 0 ið Þ; ð34Þ
where a ¼
PK
j¼1 jc,  ¼
PK
k¼1 k, and  
0 ð Þ is the trigamma
function. Since the Hessian matrix is of the form
H ¼ diagðhÞ þ 1z1T ; ð35Þ
matrix inversion can be avoided [2] and the ith component
of the correction in the iterative update rule can be found
from
ðH1gÞi ¼ ðgi  rÞ=hi; ð36Þ
where
r ¼
Xk
j¼1
ðgj=hjÞ
 !
= z1 þ
Xk
j¼1
h1j
 !
: ð37Þ
A.2 Variational Parameters
First, Qkga appears in terms 3, 4, and 5 of (25). Taking these
terms, removing summations over k, a, and g and adding a
Lagrangian to satisfy the summation constraint, we have
Qkga logNðegajk; gk; gkÞ Qkga logQkga þQkgaEpðjaÞ
½log k  
X
a
Qkga  1
 !
;
ð38Þ
taking partial derivatives with respect to Qkga and setting
these to zero gives
0¼ logNðegajk; gk; gkÞðlog½Qkga þ 1Þ þEpðjaÞ½log k  ;
ð39Þ
solving for  and rearranging gives the following update for
Qkga
Qkga ¼
Nðegajk; gk; gkÞ exp½EpðjaÞ½log kPA
a0¼1Nðega0 jk; gk; gkÞ exp½Epðja0 Þ½log k
; ð40Þ
where
EpðjaÞ½log k ¼ ðakÞ 
X
j
aj
 !
: ð41Þ
Now, the ak variable appears in terms 1, 2, and 5 of the
above bound. Extracting these terms and removing summa-
tions over k and a leaves
EpðjaÞ½log pðjaÞ þEpðjaÞ½log pðjÞ
þ
X
g
QkgaEpðjaÞ½log k: ð42Þ
Now,
EpðjaÞ½log pðjaÞ ¼
Z

log
ðPk akÞQ
k ðakÞ
þ
X
k
ðak  1Þ log½k
" #
pðjaÞd
¼ log ð
P
k akÞQ
k ðakÞ
 
þ
X
k
ðak  1ÞEpðjaÞ
½log k
¼ log ð
P
k akÞQ
k ðakÞ
 
þ
X
k
ðak  1Þ
½ðakÞ 
X
j
aj
 !
;
ð43Þ
and similarly for the pðjÞ term. Therefore, the relevant
terms simplify to the following (again, omitting unneces-
sary summations and non-ak terms)
kakþ
X
g
Qkga
 !
ðakÞ 
X
j
aj
 !" #
log ð
P
k akÞQ
k ðakÞ
 
:
ð44Þ
Taking partial derivatives with respect to ak and setting
these to zero leaves
k  ak þ
X
g
Qkga
 !
0ðakÞ 0
X
j
aj
 !" #
¼ 0; ð45Þ
giving the following update for ak
ak ¼ k þ
X
g
Qkga: ð46Þ
A.3 Pseudocode Listings
Algorithm 1: Latent Process Decomposition algorithm. We
used a tolerance tol1 ¼ 105 to avoid Gaussians collapsing
onto a single point, and tol2 ¼ 1010 for the  updating.
Parameter Initialization. From (6), we can see that in
order to update Qkga, we need values for gk, gk, and ak.
The first two are initialized to the array means and standard
deviations, respectively. The ak values were initialized to
positive random numbers since, with the means and
standard deviations uniform over the K processes, uniform
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ak values would place the algorithm in a local minima of
the likelihood and training could not proceed.
Numerical Stability. There are several points where the
algorithm could potentially lose numerical stability. If a
Gaussian contracts onto a single point, its standard
deviation will shrink to zero and its probability density
function will approach 1. To avoid this, we apply a lower
bound to the value of 2gk. The choice of the value of this
bound is important since, if the value is too low, numerical
problems will persist, while if it is too high it would
overconstrain the model and prevent it from fitting the data.
For the update equation for Qkga, we find a second possible
source of instability. From (6), we occasionally find that we
reach the limits of machine precision and both the
numerator and the denominator approach zero. To circum-
vent this, we added a small constant (10100) to each value
in Q before normalization (i.e., before performing the
division in (6)). Finally, when calculating the likelihood,
we have to compute a product over the g. For a large
number of genes, this product soon becomes smaller than
the machine precision. However, we are ultimately inter-
ested in the logarithm of this product (the log-likelihood)
and so we can perform the following numerical trick to
avoid a problem. Namely, we observe that the expression
we wish to evaluate is of the form log
P
i
Q
j Rij. This can be
rewritten
log
X
i
exp 	i
" #
¼ log
X
i
expf	i þKg expðKÞ
" #
¼ log
X
i
expð	i þKÞ
" #
K;
if 	i ¼
P
j logRij, which can be readily evaluated given a
suitable choice for K. Given that the 	i values will all be
negative, a suitable choice is max½	i so that we are
effectively incrementing all 	i values so that the maximum
value is 0. Following the implementation of these precau-
tions, the algorithm is robust.
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